Evidence map›Paper›PMID 36631721›Full record

ArticleAging clinical and experimental research2023

Effect of vitamin D supplementation on circulating fibroblast growth factor-23 concentration in adults with prediabetes.

Lisa Ceglia, Anastassios G Pittas, Bess Dawson-Hughes

Abstract read
PubMed Publisher
In one paragraph

Article in Aging clinical and experimental research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Lisa CegliaDivision of Endocrinology, Diabetes and Metabolism, Tufts Medical Center, 800 Washington St. Box 268, Boston, MA, 02111, USA. lisa.ceglia@tufts.edu.ORCID http://orcid.org/0000-0003-0023-3640
Anastassios G PittasDivision of Endocrinology, Diabetes and Metabolism, Tufts Medical Center, 800 Washington St. Box 268, Boston, MA, 02111, USA.
Bess Dawson-HughesBone Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA.
Tufts University · USTufts Medical Center · US

Funding

Vitamin D and Type 2 Diabetes (D2d)U01DK098245 · NIDDK · TUFTS MEDICAL CENTER · PI PITTAS, ANASTASSIOS G · 2013 to 2020
$45.6M
Vitamin D for Type 2 Diabetes (D2D trial)U34DK091958 · NIDDK · TUFTS MEDICAL CENTER · PI PITTAS, ANASTASSIOS G · 2011 to 2012
$792k
NIDDK NIH HHS U01 DK098245NIDDK NIH HHS U01DK098245NIDDK NIH HHS U34 DK091958Office of Dietary Supplements U01DK098245U.S. Department of Agriculture 58-1950-7-707
6 · The paper itself

Abstract

backgroundRecent meta-analyses report that vitamin D supplementation increases blood fibroblast growth factor-23 (FGF23) level.

objectivesTo determine the effect of 4000 IU/day of vitamin D

methodsAn ancillary analysis among adults 70 years and older with prediabetes who participated in a trial comparing vitamin D

resultsCharacteristics of the 52 participants (vitamin D

conclusionIn obese older adults with sufficient vitamin D status and normal renal function, vitamin D CLINICALTRIALS: gov NCT 01,942,694, registered 9/16/2013.

Indexed as

Prediabetic StateVitamin D DeficiencyAgedCholecalciferolDietary SupplementsDouble-Blind MethodFemaleFibroblast Growth Factor-23HumansMaleVitamin DCholecalciferolFGF23 protein, humanFibroblast Growth Factor-23Vitamin D25-hydroxyvitamin DFGF23PrediabetesVitamin D

Identifiers

PMID36631721
OpenAlexW4315642052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.